8328 J. Am. Chem. Soc., Vol. 123, No. 34, 2001
McGuinness et al.
100 mL), and a MeOH solution of AgBF4 (prepared from 3.20 g, 0.0138
mol of Ag2O and 3.4 mL of 50% HBF4 solution) was added. The
solution was dried over molecular sieves and filtered to remove AgI,
and the solvent was removed in vacuo until ca. 20 mL remained. Ether
(20 mL) was added, and the solvent was decanted. The remaining oil
was washed with ether, dried in vacuo, and washed again with ether.
Drying in vacuo over a warm water bath gave a white powder. Yield:
CyC). 31P NMR (162 MHz, CD2Cl2): δ 29.1 (d with Pt satellites, JP-P
) 18 Hz, JP-Pt ) 1265 Hz), 29.7, 29.8 (two doublets attributed to two
conformations of the bulky PCy3 ligand, with Pt satellites, JP-P ) 18
Hz, JP-Pt ) 990 Hz).
[PtH(dmty)(PCy3)2]BF4 (12). This was prepared in the same manner
as 10, from Pt(PCy3)2 (0.080 g, 0.10 mmol) and 3,4-dimethylthiazolium
tetrafluoroborate (0.087 g, 0.43 mmol) to yield a yellow powder.
Yield: 0.022 g (23%). Anal. Calcd for C41H74NSP2PtBF4: C, 51.46;
H, 7.79; N, 1.46. Found: C, 51.33; H, 8.38; N, 1.38. MS (LSIMS):
m/z (relative intensity) 869 [M]+ (80), 755 [Pt(PCy3)2]+ (55), 588 [Pt-
(PCy3)2 - Cy]+ (100), 504 [Pt(PCy3)2 - 2Cy]+ (25), 281 [HPCy3]+
1
2.79 g (53%). H NMR (200 MHz, D2O): δ 9.75 (s, 1H, SC(H)N),
7.76 (s, 1H, SCH), 4.10 (s, 3H, NCH3), 2.54 (s, 3H, CCH3). 13C NMR
(50 MHz, D2O): δ 160.5 (SCN), 123.0 (NCCH3), 116.0 (SC), 42.5
(NCH3), 15.3 (CCH3).
1
[PtI(tmiy)(PPh3)2]BF4 (9). 2-Iodo-1,3,4,5-tetramethylimidazolium
tetrafluoroborate (0.0403 g, 0.119 mmol) and Pt(PPh3)4 (0.144 g, 0.116
mmol) were taken up in THF (30 mL) and heated to 65 °C for 24 h.
The solvent was removed until ca. 2 mL remained, ether (10 mL) was
added, and the solvent was decanted off the precipitate. After washing
with THF/ether (2 mL/10 mL) and ether (2 × 5 mL), the product was
dried in vacuo to give a white powder. Yield: 0.109 g (89%). Anal.
Calcd for C43H42N2IP2PtBF4: C, 48.83; H, 4.00; N, 2.65. Found: C,
48.09; H, 4.24; N, 2.42. MS (LSIMS): m/z (relative intensity) 970
(70). H NMR (200 MHz, CD2Cl2): δ 7.27 (s with Pt satellites, JPt-H
) 7 Hz, 1H, SCH), 3.96 (s, 3H, NCH3), 2.44 (s, 3H, CCH3), 0.8-2.2
(m, 66H, CyH), -7.49 (dd with Pt satellites, JP-H ) 24, 159 Hz, JPt-H
) 444 Hz, 1H, PtH). 13C NMR (100 MHz, CD2Cl2): δ 38.2 (NCH3),
35.9 (d, CyC), 30.6 (CyC), 30.4 (m, CyC), 27.6 (m, CyC), 27.2 (CyC),
26.5 (d, CyC), 14.6 (CCH3). 31P NMR (161 Hz, CD2Cl2): δ 28.9 (d,
with Pt satellites, JP-P ) 15 Hz, JPt-P ) 1278 Hz), 27.0 (“t” attributed
to conformations of the PCy3 ligand, with Pt satellites, JP-P ) 15 Hz,
JPt-P ) 985 Hz).
1
[M]+ (11); 708 [M - PPh3]+ (10); 580 [M - PPh3I]+ (25). H NMR
Pd(dcype)(dba) (13). Pd(dba)2 (0.59 g, 1.03 mmol) and dcype (0.44
g, 1.04 mmol) were dissolved in toluene (30 mL) and stirred for 3
days. The solvent was removed in vacuo, and the residue was taken
up in THF (25 mL) and filtered through Celite. The THF was removed
in vacuo until ca. 5 mL remained, and pentane (20 mL) was added to
precipitate the product. The solvent was decanted off, the solid washed
with pentane/ether (10 mL/10 mL, 3×), and the product dried in vacuo
to give an orange powder. Yield: 0.426 g (54%). MS (LSIMS): m/z
(relative intensity) 763 [M]+ (20), 528 [M - dba]+ (100), 445 [M -
dba - Cy]+ (33), 363 [M - dba - 2Cy]+ (35), 281 [M - dba -
(200 MHz, CD2Cl2): δ 7.6-7.4 (m, 30H, phenylH), 3.11 (singlet with
Pt satellites, JPt-H ) 3 Hz, 6H, NCH3), 1.62 (s, 6H, CCH3). 13C NMR
(100 MHz, CD2Cl2) δ: 134.3 (singlet with Pt satellites, JPt-C ) 6 Hz,
phenylC), 131.6 (phenylC), 128.9 (m, phenylC), 128.7 (singlet with Pt
satellites, JPt-C ) 5 Hz, CdC), 127.0 (phenylC), 34.3 (NCH3), 8.6
(CCH3). 31P NMR (161 Hz, CD2Cl2): δ 13.8 (singlet with Pt satellites,
JP-Pt ) 1234 Hz).
[PtH(dmiy)(PPh3)2]BF4 (10). Pt(PPh3)2 (0.247 g, 0.343 mmol) was
dissolved in 10 mL of THF, and a solution of 1,3-dimethylimidazolium
tetrafluoroborate (0.126 g, 0.68 mmol) in 10 mL of acetone was added.
The heterogeneous solution was stirred at 60 °C for 18 h and filtered
through Celite. The solvent was removed in vacuo, and the residue
was taken up in 2.5 mL of DCM and extracted with water (3 × 4 mL).
The solvent was then removed in vacuo, and the product was washed
further with water (2 × 4 mL) and ether (2 × 5 mL). Drying in vacuo
gave a white powder. Yield: 0.196 g (63%). Anal. Calcd for
C41H39N2P2PtBF4: C, 54.50; H, 4.35; N, 3.10. Found: C, 54.32; H,
4.32; N, 3.02. HRMS (LSIMS): m/z calcd for C41H39N2P2195Pt,
816.22361; found, 816.22419. MS (LSIMS): m/z (relative intensity)
816 [M]+ (100); 719 [Pt(PPh3)2]+ (50); 553 [M - PPh3H]+ (80); 455
1
3Cy]+ (28). H NMR (200 MHz, CD2Cl2, -40 °C): δ 6.8-7.8 (m,
12H, PhH, HCdCH), 5.01 (m, 1H, HCdCH), 4.83 (m, 1H, HCdCH),
0.5-2.2 (br, m, 48H, CyH, PCH2). 13C NMR (50 MHz, CD2Cl2, -60
°C): δ 129.7, 129.6, 129.1 (PhC), 25.9-27.9 (m, CyC). 31P NMR (161
Hz, CD2Cl2, 15 °C): δ -1.29, -3.56 (s, br).
[PdI(dcype)(tmiy)]BF4 (14). This complex was prepared by a
method similar to that employed for the synthesis of 9, from Pd(dcype)-
(dba) (13) (0.095 g, 0.12 mmol) and 2-iodo-1,3,4,5-tetramethylimida-
zolium tetrafluorborate (0.0426, 0.126) to afford an orange powder.
Yield: 0.075 g (72%). Anal. Calcd for C33H60N2P2IPdBF4: C, 45.72;
H, 6.98; N, 3.23. Found: C, 45.47; H, 6.45; N, 3.44. MS (LSIMS):
m/z (relative intensity) 779 [M]+ (10), 655 [M - tmiy]+ (65). 1H NMR
(400 MHz, CD2Cl2): δ 3.76 (s, 6H, NCH3), 2.23 (s, 6H, CCH3), 1.2-
2.2 (broad humps, 48H, CyH, PCH2). 13C NMR (100 MHz, CD2Cl2):
δ 127.3 (CdC), 33.6 (NCH3), 30.6, 29.4, 26.9 (br), 25.8 (CyC, PCH2),
8.2 (H3CCCCH3).
1
[PPh3]+ (25). H NMR (200 MHz, CD2Cl2): δ 6.79 (singlet with Pt
satellites, JPt-H ) 6 Hz, 2H, HCdCH), 3.50 (singlet with Pt satellites,
JPt-H ) 2 Hz, 6H, NCH3), -5.23 (dd with Pt satellites, JP-H ) 19, 176
Hz, JPt-H ) 511 Hz, 1H, PtH). 13C NMR (100 MHz, CD2Cl2): δ 134.3
(d, J ) 12 Hz, PhC), 133.6 (d, J ) 12 Hz, PhC), 131.2 (s, br, PhC),
128.8 (“t”, J ) 11 Hz, PhC), 122.9 (s with Pt satellites, JP-C ) 4 Hz,
JPt-C ) 16 Hz, HCdCH), 37.6 (s with Pt satellites, J ) 20 Hz, NCH3).
Acknowledgment. We are indebted to the Australian
Research Council for financial support and for providing an
Australian Postgraduate Award for D.S.M. We also thank
Johnson-Matthey for the generous loan of Pd and Pt salts. The
staff of the Central Science Laboratory (University of Tasmania)
are gratefully acknowledged for their assistance in a number of
instrumental techniques.
31P NMR (161.8 MHz, CD2Cl2): δ 24.0 (d with Pt satellites, JP-P
)
18 Hz, JP-Pt ) 654 Hz), 20.1 (d with Pt satellites, JP-P ) 18 Hz, JP-Pt
) 663 Hz).
[PtH(dmiy)(PCy3)2]BF4 (11). This was prepared in the same manner
as 10 from Pt(PCy3)2 (0.099 g, 0.13 mmol) and 1,3-dimethylimidazo-
lium tetrafluoroborate (0.0248 g, 0.134 mmol) to give a white solid.
Yield: 0.074 g (60%). Anal. Calcd for C41H75N2P2PtBF4: C, 52.39;
H, 8.04; N, 2.98. Found: C, 52.29; H, 8.03; N, 2.89. MS (LSIMS):
m/z (relative intensity) 852 [M]+ (65), 756 [M - dmiyH]+ (10), 571
[M - PCy3H]+ (100), 281 [HPCy3]+ (15). 1H NMR (CD2Cl2, 400
MHz): δ 7.16 (s with Pt satellites, JPt-H ) 4 Hz, 2H, HCdCH), 3.67
(s, 6H, NCH3), 1.0-2.2 (m, 66H, CyH), -7.95 (dd with Pt satellites,
JP-H ) 160, 21 Hz, JPt-H ) 880 Hz, 1H, PtH). 13C NMR (CD2Cl2, 100
MHz): δ 123.1 (d with Pt satellites, JP-C ) 3 Hz, JPt-C ) 16 Hz,
HCdCH), 38.0-38.5 (m, CyC), 37.7 (s, NCH3), 30.8 (s with Pt
satellites, CyC), 30.7 (s, CyC), 27.9-27.7 (m, CyC), 26.6, 26.3 (s,
Supporting Information Available: Complete listing of the
optimized geometries with absolute energies of all stationary
points, and a thermal ellipsoid plot of PdCl2(dcype)‚dba (PDF).
X-ray parameters, fractional coordinates and displacement
parameters, bond lengths and bond angles for complexes 9, cis-
11, trans-11, and PdCl2(dcype)‚dba (CIF). This material is
JA010628P